XML 90 R76.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders’ Equity (Details) - USD ($)
12 Months Ended
Jan. 30, 2026
Dec. 23, 2025
Jul. 22, 2025
Jul. 18, 2025
Apr. 06, 2025
Dec. 31, 2025
Dec. 31, 2024
Mar. 07, 2025
Dec. 19, 2024
Stockholders’ Equity [Line Items]                  
Shares of common stock           205,000,000      
Common stock, shares authorized           200,000,000 200,000,000    
Common stock, par value (in Dollars per share)           $ 0.001 $ 0.001    
Common stock, shares outstanding           131,740,675 45,864,503    
Common stock shares issued           131,740,675 45,864,503    
Preferred stock, shares issued           250,000 0    
Preferred stock, shares outstanding           250,000 0    
Stock-based compensation expenses (in Dollars)           $ 859,950 $ 207,453    
RSU percentage           100.00%      
Warrant exercise price per share (in Dollars per share)       $ 0.15          
Gross proceeds (in Dollars)         $ 3,100,000 $ 25,566,385    
Fair value adjustment of warrants (in Dollars)           (604,123)    
Warrant gross proceeds (in Dollars)           3,607,710      
Net proceeds after deducting agent fees (in Dollars)           $ 1,560,000      
Common stock percentage           5.00%      
Exercise price (in Dollars per share)     $ 0.35            
Gross proceeds from offerings (in Dollars)     $ 5,000,000            
Net proceeds from offerings (in Dollars)     $ 4,500,000            
Aggregate offering price (in Dollars)                 $ 14,275,000
Share issued under the program           160,879      
Warrant [Member]                  
Stockholders’ Equity [Line Items]                  
Warrant exercise price per share (in Dollars per share)         $ 0.75        
Warrants exercise price (in Dollars per share)           $ 0.1875      
Follow-On Warrants [Member]                  
Stockholders’ Equity [Line Items]                  
Purchase of warrants         8,437,502        
Issuance of shares         4,218,751 4,218,751      
Fair value adjustment of warrants (in Dollars)         $ 515,307        
Warrant gross proceeds (in Dollars)           $ 2,934,911      
Warrants outstanding           4,114,582      
New Warrants [Member]                  
Stockholders’ Equity [Line Items]                  
Issuance of shares           7,521,668      
Warrant gross proceeds (in Dollars)           $ 5,641,251      
Warrants outstanding           915,834      
Series A-1 Warrants [Member]                  
Stockholders’ Equity [Line Items]                  
Warrants outstanding           2,113,193      
Offering by issuing (in Dollars)       $ 13,333,334          
Warrants exercised           11,220,141      
Series A-2 Warrants [Member]                  
Stockholders’ Equity [Line Items]                  
Warrants outstanding           502,081      
Offering by issuing (in Dollars)       13,333,334          
Warrants exercised           12,831,253      
Placement Agent Warrant Shares [Member]                  
Stockholders’ Equity [Line Items]                  
Purchase of warrants           666,667      
Warrant gross proceeds (in Dollars)           $ 66,406      
Warrants outstanding           312,500      
Warrants exercised           354,167      
Private Placement Warrants [Member]                  
Stockholders’ Equity [Line Items]                  
Warrant gross proceeds (in Dollars)           $ 4,596,834      
Warrants outstanding           1,151,906      
Warrants exercised           13,133,812      
RDO Placement Agent Warrants [Member]                  
Stockholders’ Equity [Line Items]                  
Purchase of warrants     714,286            
Warrant gross proceeds (in Dollars)           $ 273,437      
Warrants outstanding           89,286      
Warrants exercised           625,000      
Common stock percentage     5.00%            
Warrants exercise price (in Dollars per share)     $ 0.4375            
Warrants outstanding on December 31, 2025 [Member]                  
Stockholders’ Equity [Line Items]                  
Warrant exercise price per share (in Dollars per share)           $ 58.46      
Warrants outstanding           60,805,058      
Warrants outstanding           10,900,266      
Contractual years           3 years 4 months 13 days      
2022 Equity Incentive Plan [Member]                  
Stockholders’ Equity [Line Items]                  
Shares of common stock           412,492      
Common stock, shares authorized           15,957,189      
Common stock issued to employees           193,453      
Fair value of shares (in Dollars)           $ 105,406      
Common shares remain available for issuance           10,753,095      
July 2025 Shares [Member]                  
Stockholders’ Equity [Line Items]                  
Offering by issuing (in Dollars)       $ 13,333,334          
AGP Sales Agreement [Member]                  
Stockholders’ Equity [Line Items]                  
Warrant gross proceeds (in Dollars)           $ 2,000,000      
Restricted Stock Units (RSUs) [Member]                  
Stockholders’ Equity [Line Items]                  
Restricted stock units outstanding           4,791,602    
Number of RSUs granted           4,941,602      
Forfeited shares           150,000      
Restricted Stock Units (RSUs) [Member] | 2022 Equity Incentive Plan [Member]                  
Stockholders’ Equity [Line Items]                  
Restricted stock units outstanding           4,791,602      
Subsequent Event [Member]                  
Stockholders’ Equity [Line Items]                  
Common shares remain available for issuance 86,871                
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]                  
Stockholders’ Equity [Line Items]                  
Number of RSUs granted 3,006,233                
Minimum [Member]                  
Stockholders’ Equity [Line Items]                  
Date of grant term           2 years      
Warrant exercise price per share (in Dollars per share)         $ 0.75        
Minimum [Member] | Warrant [Member]                  
Stockholders’ Equity [Line Items]                  
Date of grant term           2 years      
Maximum [Member]                  
Stockholders’ Equity [Line Items]                  
Date of grant term           4 years      
Warrant exercise price per share (in Dollars per share)         $ 1.44        
Maximum [Member] | Warrant [Member]                  
Stockholders’ Equity [Line Items]                  
Date of grant term           5 years      
Series A Convertible Preferred Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Preferred stock, shares authorized           5,000,000      
Par value of preferred stock (in Dollars per share)           $ 0.001      
Series A Preferred Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Preferred stock, shares authorized           1,000,000      
Par value of preferred stock (in Dollars per share)           $ 20   $ 20  
Preferred stock, shares issued           250,000      
Preferred stock, shares outstanding           250,000      
Registered Offering [Member]                  
Stockholders’ Equity [Line Items]                  
Offering by issuing (in Dollars)     $ 14,285,718            
ATM [Member]                  
Stockholders’ Equity [Line Items]                  
Aggregate offering price (in Dollars)   $ 20,000,000       $ 7,650,000      
Share issued under the program   2,952,983              
Weighted average exercise price (in Dollars per share)           $ 1.44      
Gross proceeds (in Dollars)   $ 1,175,994       $ 231,235      
Commissions and offering expenses (in Dollars)           6,937      
Net Proceeds (in Dollars)           $ 224,298